Related Experiment Video
Updated: Aug 14, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
[Attitude toward insomnia: survey of 6043 French general practitioners]
D Léger1, F-A Allaert, M-A Massuel
1Centre du sommeil, Hôtel-Dieu de Paris, APHP, Paris. damien.leger@htd.ap-hop-paris.fr
Aim:
To describe the attitudes of French general practitioners (GPs) about insomnia and its effect on patients' physical health and work.
Method:
A questionnaire about patients with insomnia and its diagnosis, treatment, and consequences was distributed to a representative sample of 8000 GPs.
Results:
6,043 GPs completed and returned the questionnaires. They estimated the prevalence of insomnia in their patients at 18.1%. They identified the principal causes of insomnia as anxiety (58.8%) and work issues (54%). Nearly 45% reported that they always raise the subject of sleep with their patients. For 62.4% sleep problems reflect another disorder rather than being a primary syndrome. Nearly two-thirds (60.2%) do not prescribe medication at the first complaint. When prescribing hypnotics, 81.3% also recommended sleep hygiene measures. Most (68.5%) agreed that insomnia affects concentration, memory, and attention. Almost all employed patients with insomnia complained of work-related effects, such as loss of productivity and absenteeism.
Conclusion:
Insomnia and its management are topics of strong interest for GPs.
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Blind Procedures
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
